• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Lung cancer rapid screening test PNACIamp™
ROS1 FusionFFPE tissuesfor RT-PCR

lung cancer rapid screening test
lung cancer rapid screening test
Add to favorites
Compare this product
 

Characteristics

Applications
for lung cancer
Tested parameter
ROS1 Fusion
Sample type
FFPE tissues
Analysis mode
for RT-PCR

Description

PANAMutyper™ ROS1 Screening Kit is the qualitative diagnostic test kit which is able to detect 20 different ROS1 fusion genes of formalin-fixed paraffin-embedded (FFPE) tissue, fresh tissues and biopsy tissues from non-small cell lung cancer (NSCLC) patients using peptide nucleic acid (PNA) probes in a real-time PCR system. The PANAMutyper™ ROS1 Screening Kit is intended as an aid for screening ROS1 fusion-positive NSCLC patients who would be sensitive for receiving ROS1 inhibitor therapy such as crizotinib, Lorlatinib, etc. The PANAMutyper™ ROS1 Screening Kit is an invitro diagnostic device for detecting 20 different ROS1 fusion genes of formalin-fixed paraffin-embedded (FFPE) tissue fresh, tissues and biopsy tissues from non-small cell lung cancer (NSCLC) patients. FEATURES One-step RT-PCR technology Detection of 20 ROS1 fusion gene variants in two tube reaction High sensitivity, specificity and reproducibility Short running time Simple workflow Easy result reading by automatic analyzing program
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.